Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events.
Konstantinos N AronisM MorenoS A PolyzosJ M Moreno-NavarreteW RicartE DelgadoJ de la HeraA Sahin-EfeJ P ChamberlandR BermanA SpiroP VokonasJ M Fernández-RealC S MantzorosPublished in: International journal of obesity (2005) (2013)
This is the first study to date that demonstrates that, although circulating irisin levels do not predict the development of ACS in healthy individuals, increased irisin levels are associated with the development of MACE in patients with established coronary artery disease after PCI.